https://www.marketscreener.com/quote/stock/HILLEVAX-INC-137037473/news/HilleVax-and-Kangh-Announce-Exclusive-License-Agreement-for-Hexavalent-VLP-Norovirus-Vaccine-Candida-45691180/?utm_source=telegram&utm_medium=social&utm_campaign=share